Glycoconjugate vaccines: Principles and mechanisms

Science Translational Medicine
R Rappuoli

Abstract

Bacterial conjugate vaccines are used in infants, adolescents, and the elderly, and they are among the safest and most successful vaccines developed during the last 40 years. Conjugation of polysaccharides to proteins provides T cell epitopes that are necessary in the germinal centers for the affinity maturation of polysaccharide-specific B cells. Collective analysis of data from animal experiments and clinical trials, reviewed with current knowledge of immunology, revealed possible mechanistic explanations that may improve our understanding of conjugate vaccines. Key conclusions are that naïve infants respond differently from adolescents and adults and that most of recommended schedules generate only 10 to 35% of the maximal antibody titer that the vaccine can induce, indicating that the full potential of glycoconjugate vaccines has not yet been reached.

References

Aug 1, 1977·The Journal of Infectious Diseases·R GoldE C Gotschlich
Aug 1, 1987·The Pediatric Infectious Disease Journal·J C Parke
Oct 1, 1981·Infection and Immunity·M C SteinhoffJ B Robbins
Aug 1, 1993·American Journal of Diseases of Children·S J HolmesS Feldman
Nov 22, 2000·The Journal of Infectious Diseases·J MacLennanB Greenwood
May 30, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lisa A JacksonUNKNOWN V59P13 Study Group
May 30, 2009·Vaccine·Helen CampbellElizabeth Miller
Dec 8, 2011·Nature Medicine·Rino Rappuoli, Ennio De Gregorio
Dec 14, 2011·The Journal of Infectious Diseases·Siggeir F BrynjolfssonIngileif Jonsdottir
Jun 10, 2014·The Pediatric Infectious Disease Journal·Roger BaxterIgor Smolenov
Nov 21, 2014·Science Translational Medicine·Tom Y-H WuNicholas M Valiante
Sep 23, 2016·Immunity·Luka MesinGabriel D Victora
Sep 25, 2017·Science·Christian T MayerMichel C Nussenzweig
Dec 2, 2017·Human Vaccines & Immunotherapeutics·James M Stuart

❮ Previous
Next ❯

Citations

Jun 4, 2019·Human Vaccines & Immunotherapeutics·Louis-Antoine Barel, Laurence A Mulard
Sep 14, 2019·Toxins·Nicolas E ZaragozaEsteban Marcellin
Apr 25, 2020·Chemistry : a European Journal·Yang Yu, Martina Delbianco
Jul 29, 2020·Nature Chemical Biology·Aravind NatarajanMatthew P DeLisa
Sep 10, 2020·Proceedings of the National Academy of Sciences of the United States of America·Francesca MicoliAllan Saul
Dec 24, 2018·Proceedings of the National Academy of Sciences of the United States of America·Rino RappuoliPaolo Costantino
Feb 9, 2019·Science·John T Wilson
Jul 11, 2019·The Journal of Infectious Diseases·F Romero-SaavedraJ Huebner
Jul 7, 2020·Expert Review of Vaccines·Jennifer Mhairi DowBrendan William Wren
Nov 19, 2019·Frontiers in Chemistry·Aline PillotCyrille Grandjean
Aug 2, 2019·Nature·David GerlachAndreas Peschel
May 10, 2019·NPJ Vaccines·Emily KayBrendan W Wren
Aug 1, 2020·Frontiers in Cellular and Infection Microbiology·Malgorzata E MnichNina M van Sorge
Sep 24, 2020·Scientific Reports·Ralph N D LuetscherRichard D Cummings
Jan 13, 2021·Proceedings of the National Academy of Sciences of the United States of America·Rino RappuoliEmmanuel Hanon
Jan 17, 2021·Genome Medicine·Ruklanthi de AlwisStephen Baker
Feb 6, 2021·Nature Reviews. Microbiology·Francesca MicoliDavide Serruto
Nov 19, 2020·International Journal of Molecular Sciences·Roberta Di BenedettoFrancesca Micoli
Feb 9, 2021·Frontiers in Immunology·Eleanor C SemmesGenevieve G Fouda
Nov 6, 2020·Cells·Ermioni Kalfopoulou, Johannes Huebner
Mar 7, 2021·Vaccines·Akosiererem S SokariboAaron P White
Mar 30, 2021·Russian Journal of Bioorganic Chemistry·E A Khatuntseva, N E Nifantiev
Apr 4, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Kristen M Tummillo, Karsten R O Hazlett
May 1, 2021·Microorganisms·Mark R AldersonAnthony A Marfin
May 3, 2021·The FEBS Journal·Marko AnderluhSandra J van Vliet
Jun 17, 2021·Science Immunology·Carolina GarridoSallie R Permar
Jul 13, 2021·Biologicals : Journal of the International Association of Biological Standardization·P V S L S S Narayana, Jayati Ray Dutta
Aug 3, 2021·Chemical Reviews·Lu SuGuosong Chen
Aug 21, 2021·Frontiers in Immunology·Francesca ManciniOmar Rossi
Jul 16, 2019·Analytical Chemistry·Dustin R KleinJennifer S Brodbelt
Oct 4, 2021·Microbial Cell Factories·Marta MauriUNKNOWN Glycoengineering of Veterinary Vaccines Consortium
Oct 16, 2021·ACS Chemical Biology·Sachin S ShivatareChi-Huey Wong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Topics in Microbiology and Immunology
B A de BoerC Berek
Annals of the New York Academy of Sciences
A Gulbranson-JudgeIan C M MacLennan
Immunological Reviews
Mark J Shlomchik, Florian Weisel
© 2022 Meta ULC. All rights reserved